Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients—a case-control study-Reference-Cited by-同舟云学术

Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients—a case-control study

Published:2019-07-22 Issue:10 Volume:75 Page:1445-1450
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

van Wassenaer Elsa A.^ORCID,Meester Veronique L.,Kindermann Angelika,Koot Bart G. P.,Benninga Marc A.,de Meij Tim G. J.

Funder

Amsterdam UMC

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-019-02715-z.pdf

Reference21 articles.

1. Scallon BJ, Moore MA, Trinh H et al (1995) Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine 7:251–259. https://doi.org/10.1006/cyto.1995.0029

2. Parashette KR, Makam RC, Cuffari C (2010) Infliximab therapy in pediatric Crohn’s disease: a review. Clin Exp Gastroenterol 3:57–63

3. Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, de Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D (2014) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohn's Colitis 8:1179–1207. https://doi.org/10.1016/j.crohns.2014.04.005

4. Corica D, Romano C (2017) Biological therapy in pediatric inflammatory bowel disease a systematic review. J Clin Gastroenterol 51:100–110. https://doi.org/10.1097/MCG.0000000000000696

5. Choquette D, Faraawi R, Chow A, Rodrigues J, Bensen WJ, Nantel F (2015) Incidence and management of infusion reactions to infliximab in a prospective real-world community registry. J Rheumatol 42:1105–1111. https://doi.org/10.3899/jrheum.140538

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Accelerated Infliximab Infusions in Children With Inflammatory Bowel Disease: A Retrospective Cohort Study;Journal of Pediatric Gastroenterology & Nutrition;2023-06-15

2. Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease;Journal of Clinical Gastroenterology;2022-07-22

3. Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study;Journal of Clinical Medicine;2021-07-19

4. Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar?;Gastroenterología y Hepatología;2021-05

5. Infliximab in inflammatory bowel disease. Is premedication necessary?;Gastroenterología y Hepatología (English Edition);2021-04